Literature DB >> 6246264

Comparative biochemical studies of type 3 poliovirus.

P D Minor.   

Abstract

A study of the biochemistry of type 3 poliovirus strains which involves the examination of the virus-coded polypeptides in infected cells and the preparation of oligonucleotide maps is reported. The polypeptide patterns were shown to be a relatively stable property of virus strains and distinguished Sabin vaccine strains from wild strains of poliovirus type 3. This approach may be of value in deciding the origin (vaccine or nonvaccine) of field isolates of poliovirus. Oligonucleotide maps were found to be sensitive indicators of differences among strains and appear to form a basis for determining genetic relationships among strains. The nucleotide maps of two viruses isolated from human cases of paralytic poliomyelitis temporally associated with the administration of attenuated vaccine suggested a vaccine origin for the strain. In one case the nucleotide map was indistinguishable from that of the vaccine strain.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246264      PMCID: PMC288672     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  "Fingerprinting" high molecular weight RNA by two-dimensional gel electrophoresis: application to poliovirus RNA.

Authors:  Y F Lee; E Wimmer
Journal:  Nucleic Acids Res       Date:  1976-07       Impact factor: 16.971

2.  Characterization of the large picornaviral polypeptides produced in the presence of zinc ion.

Authors:  B E Butterworth; B D Korant
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

3.  Temperature-sensitive defect of type 2 poliovirus.

Authors:  R Adler; D R Tershak
Journal:  Virology       Date:  1974-03       Impact factor: 3.616

4.  Thermosensitive block of the Sabin strain of poliovirus type I.

Authors:  M Fiszman; M Reynier; D Bucchini; M Girard
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

5.  Degradation of poliovirus polypeptides in vivo.

Authors:  D B Garfinkle; D R Tershak
Journal:  Nat New Biol       Date:  1972-08-16

6.  Polyacrylamide gel electrophoresis of fowlpox and vaccinia virus proteins.

Authors:  J F Obijeski; E L Palmer; L G Gafford; C C Randall
Journal:  Virology       Date:  1973-02       Impact factor: 3.616

7.  Further evidence on the formation of poliovirus proteins.

Authors:  M F Jacobson; J Asso; D Baltimore
Journal:  J Mol Biol       Date:  1970-05-14       Impact factor: 5.469

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Complete translation of poliovirus RNA in a eukaryotic cell-free system.

Authors:  L Villa-Komaroff; N Guttman; D Baltimore; H F Lodishi
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

10.  Antigenic segregation of type 3 poliovirus isolates related and unrelated to Sabin's vaccine strain with the use of modified Wecker and McBride techniques.

Authors:  J H Nakano; H M Gelfand; J T Cole
Journal:  Am J Epidemiol       Date:  1966-01       Impact factor: 4.897

View more
  21 in total

1.  Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.

Authors:  Javier Martín; Elena Samoilovich; Glynis Dunn; Angie Lackenby; Esphir Feldman; Alan Heath; Ekaterina Svirchevskaya; Gill Cooper; Marina Yermalovich; Philip D Minor
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Enteroviruses in recreational waters of Northern Ireland.

Authors:  M S Hughes; P V Coyle; J H Connolly
Journal:  Epidemiol Infect       Date:  1992-06       Impact factor: 2.451

3.  Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Authors:  J Martín; G Dunn; R Hull; V Patel; P D Minor
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Long-term excretion of vaccine-derived poliovirus by a healthy child.

Authors:  Javier Martín; Kofi Odoom; Gráinne Tuite; Glynis Dunn; Nicola Hopewell; Gill Cooper; Catherine Fitzharris; Karina Butler; William W Hall; Philip D Minor
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 5.  Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses.

Authors:  A B Sabin
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

6.  An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain.

Authors:  A J Macadam; G Ferguson; C Arnold; P D Minor
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

7.  Differentiation and characterization of enteroviruses by computer-assisted viral protein fingerprinting.

Authors:  D T Holland; J Senne; C R Peter; C Urmenta; J D Connor
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine.

Authors:  S R Pollard; G Dunn; N Cammack; P D Minor; J W Almond
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.

Authors:  G D Westrop; K A Wareham; D M Evans; G Dunn; P D Minor; D I Magrath; F Taffs; S Marsden; M A Skinner; G C Schild
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

10.  Genetic and phenotypic characteristics of enterovirus 71 isolates from patients with encephalitis and with hand, foot and mouth disease.

Authors:  A Hagiwara; T Yoneyama; S Takami; I Hashimoto
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.